Patents by Inventor Alison Banham

Alison Banham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T-CELL RECEPTOR MIMIC (TCRM) ANTIBODIES
    Publication number: 20190092876
    Abstract: The present invention provides an antibody which binds to human p53 tumour suppressor protein residues 65-73 (human p5365-73), as shown in SEQ ID NO: 1, when presented by the MHC class I protein Human Leukocyte Antigen-A*0201 (HLA-A*0201).
    Type: Application
    Filed: August 26, 2016
    Publication date: March 28, 2019
    Inventors: Alison Banham, Demin Li
  • IMMUNOGENIC PEPTIDES
    Publication number: 20140010833
    Abstract: The present invention relates to immunogenic peptides and their various applications. In particular the invention relates to immunogenic peptides derived from the PASD1 protein and their use in therapeutic, diagnostic and prognostic methods.
    Type: Application
    Filed: July 10, 2013
    Publication date: January 9, 2014
    Inventors: Karen Pulford, Alison Banham, Amanda Anderson, Kamel Ait-Tahar
  • Immunogenic peptides
    Patent number: 8501908
    Abstract: The present invention relates to immunogenic peptides and their various applications. In particular the invention relates to immunogenic peptides derived from the PASD1 protein and their use in therapeutic, diagnostic and prognostic methods.
    Type: Grant
    Filed: October 1, 2009
    Date of Patent: August 6, 2013
    Assignee: Isis Innovation Ltd.
    Inventors: Karen Pulford, Alison Banham, Amanda Anderson, Kamel Ait-Tahar
  • IMMUNOGENIC PEPTIDES
    Publication number: 20120042399
    Abstract: The present invention relates to immunogenic peptides and their various applications. In particular the invention relates to immunogenic peptides derived from the PASD1 protein and their use in therapeutic, diagnostic and prognostic methods.
    Type: Application
    Filed: October 1, 2009
    Publication date: February 16, 2012
    Inventors: Karen Pulford, Alison Banham, Amanda Anderson, Kamel Ait-Taho-ar
  • USE OF FOXP2 AS A MARKER FOR ABNORMAL LYMPHOCYTES AND AS A TARGET FOR THERAPY OF DISORDERS ASSOCIATED WITH ABNORMAL LYMPHOCYTES
    Publication number: 20110300128
    Abstract: The present invention is directed to a method for detecting abnormal lymphocytes said method comprising detecting an amount or expression of the FOXP2 gene in lymphocytes in a sample, wherein an increased amount or expression of the FOXP2 gene in said lymphocytes indicates the presence of abnormal lymphocytes. Additionally, the invention concerns a method for detecting or assessing a condition associated with the presence of abnormal lymphocytes. The methods of the invention may also be useful for diagnosing myeloma or MGUS or for determining the prognosis for patients with lymphoma, myeloma or MGUS. The severity of bone disease or bone colonisation of tumours may also be able to be predicted. Further, treatment of conditions associated with the presence of abnormal lymphocytes using an agent which inhibits FOXP2 expression and/or FOXP2 activity is provided. An antibody which binds to the N-terminus of FOXP2 has also been developed.
    Type: Application
    Filed: December 16, 2009
    Publication date: December 8, 2011
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Alison Banham, Andrew Campbell, Duncan Gascoyne, Linden Lyne
  • Tumour associated antigens
    Publication number: 20050158737
    Abstract: There are disclosed a number of tumour associated antigens that can be utilised in the diagnosis and treatment of tumours in a patient. Methods of treating patients having such tumours are also disclosed.
    Type: Application
    Filed: September 27, 2004
    Publication date: July 21, 2005
    Inventors: Alison Banham, Karen Pulford, Amanda Liggins, Barbara Guinn